伦敦初创公司Baseimmune近日宣布，该公司在A轮融资中成功筹集了1130万美元，用于进一步开发其机器学习平台，旨在简化疫苗设计流程。本轮融资由MSD全球健康创新基金、IQ资本等机构领投，并获得了Hoxton Ventures、Creator Fund、Beast Ventures和Maki.vc等早期支持者的积极参与。
Baseimmune是一家总部位于伦敦的生物技术初创公司，专注于利用人工智能技术设计和开发疫苗。此次A轮融资的成功，标志着该公司在疫苗研发领域的创新能力和市场潜力得到了投资者的认可。资金将主要用于加速其机器学习平台的发展，以及推进基于该平台的新疫苗候选物的临床试验。
Baseimmune的机器学习平台能够快速识别和优化疫苗设计，从而缩短疫苗研发的时间和成本。这种技术的应用有望在应对新兴传染病威胁和加快疫苗更新迭代方面发挥重要作用。
此次融资的超额认购显示了投资者对Baseimmune潜力的信心，同时也凸显了全球对创新疫苗技术需求的日益增长。随着Baseimmune机器学习平台的不断成熟和应用，未来有望为全球公共卫生事业做出重要贡献。
英语如下：
News Title: “AI Vaccine Design Platform Baseimmune Secures $11.3 Million Financing to Advance Vaccine Simplification Revolution”
Keywords: AI vaccine, Baseimmune, $11.3 million financing
News Content:
London-based startup Baseimmune recently announced that it successfully raised $11.3 million in its Series A round of financing to further develop its machine learning platform aimed at simplifying the vaccine design process. The round was led by the MSD Global Health Innovation Fund and IQ Capital, with active participation from early supporters such as Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc.
Baseimmune, a biotechnology startup headquartered in London, focuses on using artificial intelligence technology to design and develop vaccines. The successful completion of its Series A financing marks the recognition of the company’s innovative capabilities and market potential in the field of vaccine research and development. The funds will be primarily used to accelerate the development of its machine learning platform and to advance the clinical trials of new vaccine candidates based on this platform.
Baseimmune’s machine learning platform can rapidly identify and optimize vaccine designs, thereby shortening the time and costs of vaccine development. The application of this technology has the potential to play a significant role in responding to emerging infectious disease threats and accelerating the update of vaccines.
The oversubscription of the financing round reflects investors’ confidence in Baseimmune’s potential and highlights the growing demand for innovative vaccine technologies globally. As Baseimmune’s machine learning platform continues to mature and be applied, it is expected to make a significant contribution to global public health in the future.
【来源】https://www.maginative.com/article/baseimmune-closes-11-3m-series-a-to-accelerate-ai-designed-vaccines/
Views: 1